These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35608913)

  • 1. Isolevuglandins disrupt PU.1-mediated C1q expression and promote autoimmunity and hypertension in systemic lupus erythematosus.
    Patrick DM; de la Visitación N; Krishnan J; Chen W; Ormseth MJ; Stein CM; Davies SS; Amarnath V; Crofford LJ; Williams JM; Zhao S; Smart CD; Dikalov S; Dikalova A; Xiao L; Van Beusecum JP; Ao M; Fogo AB; Kirabo A; Harrison DG
    JCI Insight; 2022 Jul; 7(13):. PubMed ID: 35608913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus.
    Mok CC; Ho LY; Leung HW; Wong LG
    Transl Res; 2010 Dec; 156(6):320-5. PubMed ID: 21078493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-C1q antibodies in systemic lupus erythematosus.
    Orbai AM; Truedsson L; Sturfelt G; Nived O; Fang H; Alarcón GS; Gordon C; Merrill J; Fortin PR; Bruce IN; Isenberg DA; Wallace DJ; Ramsey-Goldman R; Bae SC; Hanly JG; Sanchez-Guerrero J; Clarke AE; Aranow CB; Manzi S; Urowitz MB; Gladman DD; Kalunian KC; Costner MI; Werth VP; Zoma A; Bernatsky S; Ruiz-Irastorza G; Khamashta MA; Jacobsen S; Buyon JP; Maddison P; Dooley MA; Van Vollenhoven RF; Ginzler E; Stoll T; Peschken C; Jorizzo JL; Callen JP; Lim SS; Fessler BJ; Inanc M; Kamen DL; Rahman A; Steinsson K; Franks AG; Sigler L; Hameed S; Pham N; Brey R; Weisman MH; McGwin G; Magder LS; Petri M
    Lupus; 2015 Jan; 24(1):42-9. PubMed ID: 25124676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
    Julkunen H; Ekblom-Kullberg S; Miettinen A
    Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
    Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH
    Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Double-Stranded DNA Isotypes and Anti-C1q Antibody Improve the Diagnostic Specificity of Systemic Lupus Erythematosus.
    Jia Y; Zhao L; Wang C; Shang J; Miao Y; Dong Y; Zhao Z
    Dis Markers; 2018; 2018():4528547. PubMed ID: 30363714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide treatment for hypertension and renal injury in an experimental model of systemic lupus erythematosus.
    Wolf VL; Taylor EB; Ryan MJ
    Physiol Rep; 2019 May; 7(10):e14059. PubMed ID: 31124322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-C1q in systemic lupus erythematosus.
    Stojan G; Petri M
    Lupus; 2016 Jul; 25(8):873-7. PubMed ID: 27252264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
    Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of anti-nuclesome and anti C1q antibodies with lupus nephritis in an Egyptian cohort of patients with systemic lupus erythematosus.
    Metwally IM; Eesa NN; Yacoub MH; Elsman RM
    Adv Rheumatol; 2019 Mar; 59(1):10. PubMed ID: 30832710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-C1q autoantibodies from patients with systemic lupus erythematosus induce C1q production by macrophages.
    Thanei S; Trendelenburg M
    J Leukoc Biol; 2017 Feb; 101(2):481-491. PubMed ID: 27630215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site.
    Csorba K; Schirmbeck LA; Tuncer E; Ribi C; Roux-Lombard P; Chizzolini C; Huynh-Do U; Vanhecke D; Trendelenburg M
    Front Immunol; 2019; 10():2619. PubMed ID: 31787984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Cell Depletion Attenuates Hypertension in an Experimental Model of Autoimmune Disease.
    Taylor EB; Barati MT; Powell DW; Turbeville HR; Ryan MJ
    Hypertension; 2018 Apr; 71(4):719-728. PubMed ID: 29378858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of C1q and C1q receptors in the pathogenesis of systemic lupus erythematosus.
    Ghebrehiwet B; Peerschke EI
    Curr Dir Autoimmun; 2004; 7():87-97. PubMed ID: 14719376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating microparticles in systemic Lupus Erythematosus.
    Nielsen CT
    Dan Med J; 2012 Nov; 59(11):B4548. PubMed ID: 23171755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.
    Shang X; Ren L; Sun G; Yu T; Yao Y; Wang L; Liu F; Zhang L; He X; Liu M
    Immun Inflamm Dis; 2021 Jun; 9(2):407-418. PubMed ID: 33470559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus Erythematosus.
    Kleer JS; Rabatscher PA; Weiss J; Leonardi J; Vogt SB; Kieninger-Gräfitsch A; Chizzolini C; Huynh-Do U; Ribi C; Trendelenburg M
    Front Immunol; 2021; 12():761395. PubMed ID: 35087514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmunity and SLE: Factual and Semantic Evidence-Based Critical Analyses of Definitions, Etiology, and Pathogenesis.
    Rekvig OP
    Front Immunol; 2020; 11():569234. PubMed ID: 33123142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
    Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P
    J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.